Explore the evolution of the FDA over the past century and its role in navigating modern healthcare challenges in this 44-minute talk featuring Amy Abernethy, Principal Commissioner of the FDA, and Vijay Pande, GP on the Bio Fund at a16z. Delve into the agency's approach to emerging technologies like CRISPR, synthetic biology, and AI in medicine. Learn about the FDA's drug approval process, risk management strategies, and responses to crises like the opioid epidemic. Discover how the agency is adapting to innovations in bioengineering, personalized therapies, and food safety. Gain insights on the future of clinical trials, healthcare privacy, and the FDA's vision for the next century of public health regulation.
Food, Drugs, and Tech: 100 Years of Public Health - FDA's Evolution and Future Challenges
Overview
Syllabus
What the FDA looks like today and the key steps of the FDA process to getting a drug/product to market []
How to manage a culture when mitigating risk is a top priority while aiming to innovate for the future []
Creative problem-solving in times of crisis, such as the Opioid crisis []
Preparing for and preventing drug shortages at scale []
How advances in bioengineering are transforming healthcare []
How the FDA is thinking about n=1 therapies and its applications in the future []
The future of healthcare privacy []
The ways the clinical trial process are shifting []
Innovations in Bioengineering as they relate to regulating food in the future []
How the FDA handles foodborne illnesses and its plans to innovate food safety []
Discussion about the next 100 years of the FDA []
Taught by
a16z
